(Q40418515)

English

Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 September 2017

Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models (English)

1 reference

Europe PubMed Central

20 September 2017

author name string

Andrew M Davidoff

1

1 reference

Europe PubMed Central

20 September 2017

John T Gray

2

1 reference

Europe PubMed Central

20 September 2017

Catherine Y C Ng

3

1 reference

Europe PubMed Central

20 September 2017

Youbin Zhang

4

1 reference

Europe PubMed Central

20 September 2017

Junfang Zhou

5

1 reference

Europe PubMed Central

20 September 2017

Yunyu Spence

6

1 reference

Europe PubMed Central

20 September 2017

Yusura Bakar

7

1 reference

Europe PubMed Central

20 September 2017

Amit C Nathwani

8

1 reference

Europe PubMed Central

20 September 2017

publication date

1 June 2005

1 reference

Europe PubMed Central

20 September 2017

Molecular Therapy

1 reference

Europe PubMed Central

20 September 2017

11

1 reference

Europe PubMed Central

20 September 2017

6

1 reference

Europe PubMed Central

20 September 2017

875-888

1 reference

Europe PubMed Central

20 September 2017

Immune responses to recombinant adeno-associated virus vectors: putting preclinical findings into perspective

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.022

7 January 2021

Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.022

7 January 2021

Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.022

7 January 2021

Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.022

7 January 2021

Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.022

7 January 2021

Improved hepatic gene transfer by using an adeno-associated virus serotype 5 vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.022

7 January 2021

Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.022

7 January 2021

Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.022

7 January 2021

Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.022

7 January 2021

Identification of PDGFR as a receptor for AAV-5 transduction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.022

7 January 2021

Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.022

7 January 2021

Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.022

7 January 2021

Characterization of the transcription profile of adeno-associated virus type 5 reveals a number of unique features compared to previously characterized adeno-associated viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.022

7 January 2021

A limited number of transducible hepatocytes restricts a wide-range linear vector dose response in recombinant adeno-associated virus-mediated liver transduction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.022

7 January 2021

Transfer of contaminants in adeno-associated virus vector stocks can mimic transduction and lead to artifactual results

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.022

7 January 2021

Total correction of hemophilia A mice with canine FVIII using an AAV 8 serotype.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.022

7 January 2021

Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.022

7 January 2021

Long-term stability of large insert genomic DNA episomal shuttle vectors in human cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.022

7 January 2021

AAV serotype 2 vectors preferentially integrate into active genes in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.022

7 January 2021

Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.022

7 January 2021

Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.022

7 January 2021

Sex significantly influences transduction of murine liver by recombinant adeno-associated viral vectors through an androgen-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.022

7 January 2021

Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.022

7 January 2021

Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.022

7 January 2021

A single-step affinity column for purification of serotype-5 based adeno-associated viral vectors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.022

7 January 2021

Purification of recombinant adeno-associated virus type 8 vectors by ion exchange chromatography generates clinical grade vector stock

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.022

7 January 2021

Efficient gene transfer into human cord blood CD34+ cells and the CD34+CD38- subset using highly purified recombinant adeno-associated viral vector preparations that are free of helper virus and wild-type AAV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.12.022

7 January 2021

Identifiers

10.1016/J.YMTHE.2004.12.022

1 reference

Europe PubMed Central

20 September 2017

1 reference

Europe PubMed Central

20 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40418515&oldid=1897302157"